No Picture
Healthcare

Stealth BioTherapeutics (NASDAQ: MITO) Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium

SBT-272 improved neuronal health, superior to other approved and investigational agents Phase 1 study to evaluate safety and tolerability of SBT-272 in healthy volunteers is underway BOSTON, June 8, 2022 — Stealth BioTherapeutics Corp (NASDAQ: MITO), […]

No Picture
Healthcare

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax (NASDAQ: NVAX) COVID-19 Vaccine for People Aged 18 Years and Older

Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the […]

Healthcare

Nova Mentis (OTC: NMLSF) Receives Controlled Substances Export Approval From The U.S. DEA For The Company’s Proprietary Psilocybin Drug NM 1001

Vancouver, British Columbia– June 7, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]

Newsmakers

DeepMarkit (OTC: MKTDF) Contributes Response to Current Industry Dialogue Regarding Tokenization of Carbon Credits

The Company’s MintCarbon.io platform mints only 100% verified carbon credits registered on the Gold Standard or Verra Registries and Other Reputable Registries Retired, Expired or Otherwise Inferior Credits are not Eligible for Minting on MintCarbon.io […]

Newsmakers

DeepMarkit (OTC: MKTDF) Welcomes Added Validation of its Business Model as Venture Capital Firms Lead US$70 Million Investment in Recent Industry Deal

VC Firms Andreessen Horowitz, General Catalyst and Samsung Next, to name a few, backed the latest large deal that is drawing attention to the carbon credit industry Flowcarbon’s ability to raise US$70 Million demonstrates a growing level […]

No Picture
Healthcare

Kiromic BioPharma (NASDAQ: KRBP) Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement

In Vivo Preclinical Data Expected to Enable Three New IND Applications to Evaluate Company’s Gamma Delta T cell Product Candidates Procel™, Isocel™, and Deltacel™ HOUSTON, June 07, 2022—-Kiromic BioPharma, Inc. (NASDAQ: KRBP), a clinical-stage biotherapeutics company […]

No Picture
Healthcare

Tonix Pharmaceuticals (NASDAQ: TNXP) Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology

Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines TNX-1840 and TNX-1850 are Potential RPV Vaccines Designed to Protect Against COVID-19 Confirms Leadership Position in Synthetic Biology Statutory Term of New Patent Expected to Provide Exclusivity […]

Newsmakers

DeepMarkit (OTC: MKTDF) Secures Carbon Credits for Second Stage MintCarbon.io Platform Test and NFT Market Validation

MintCarbon.io platform to be tested with a higher volume of carbon credits than has been performed to date Post-mint NFT pricing and secondary market transactions to be observed in proof-of-market validation DeepMarkit and Climate Carbon […]

Newsmakers

PharmaDrug (OTC: LMLLF) Announces Closing of the First Tranche of Non-Brokered Private Placement

Toronto, Ontario– May 27, 2022 – PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, […]